newsfilter
← Latest News
GlobeNewswire·

Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging

BASKING RIDGE, N.J. and HOUSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of